Onyx Pharmaceuticals, Inc. (ONXX) Misses Q1 EPS by 13c

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) reported Q1 EPS of ($0.68), $0.13 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $72 million versus the consensus estimate of $69.82 million.

For earnings history and earnings-related data on Onyx Pharmaceuticals, Inc. (ONXX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c